PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (SKIN + HAIR)
DRUG NAME: OS-01

• FDA Safety Data Sheet not available (experimental peptide).

• Zonari A. Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models. NPJ Aging. 2023 [PubMed Link]

• Zonari A. OS-01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12-Week Clinical Trial. J Cosmet Dermatol. 2025 [PubMed Link]

• Zonari A. Double-blind, vehicle-controlled clinical investigation of peptide OS-01 for skin rejuvenation. J Cosmet Dermatol. 2024 [PubMed Link]

• Zonari A. Clinical efficacy of OS-01 peptide formulation in reducing the signs of periorbital skin aging. Int J Cosmet Sci. 2025 [PubMed Link]